FDA Approves First Gene Therapy To Treat Deafness

FDA Approves First Gene Therapy To Treat Deafness Authored by Zachary Stieber via The Epoch Times (emphasis ours), Federal regulators on Thursday approved the first gene therapy to restore hearing, just two months after the therapy’s maker formally requested a license. Dr. Marty Makary, the Food and Drug Administration's commissioner, in an undated file photograph. Madalina Vasiliu/The Epoch Times The Food and Drug Administration approved the Regeneron therapy, Otarmeni, for children and adults with severe or profound hearing loss associated with OTOF gene variants. The approval came 61 days after Regeneron filed for a...